Cargando…

1523. Impact of Antiretroviral Therapy (ART) on All-Cause Mortality in HIV from 1999 to 2020 in the United States

BACKGROUND: Over the last two decades, Antiretroviral Therapy (ART) has evolved dramatically in the United States (U.S.) from multi-tablet regimens (MTR) to single tablet regimens (STR) and from Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) and Protease Inhibitor (PI) based regimens to inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Prince, Monique A, Tan, Min-Choon, Tan, Min-Xuan, Prince, E’ebony, Nicholas, Rick, Shaaban, Hamid, Slim, Jihad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679375/
http://dx.doi.org/10.1093/ofid/ofad500.1358
_version_ 1785150577869586432
author Prince, Monique A
Tan, Min-Choon
Tan, Min-Xuan
Prince, E’ebony
Nicholas, Rick
Shaaban, Hamid
Slim, Jihad
author_facet Prince, Monique A
Tan, Min-Choon
Tan, Min-Xuan
Prince, E’ebony
Nicholas, Rick
Shaaban, Hamid
Slim, Jihad
author_sort Prince, Monique A
collection PubMed
description BACKGROUND: Over the last two decades, Antiretroviral Therapy (ART) has evolved dramatically in the United States (U.S.) from multi-tablet regimens (MTR) to single tablet regimens (STR) and from Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) and Protease Inhibitor (PI) based regimens to integrase inhibitor (INI) based ART. This study sought to determine the trends in all-cause mortality over time as ART trends changed. METHODS: We queried the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database and performed serial cross-sectional analyses of national death certificate data for all-cause mortality with comorbid HIV from 1999 to 2020. HIV diseases (ICD-10 B20-B24, O98.7, R75) were listed as the contributing cause of death. We calculated age-adjusted mortality rates (AAMR) per 1,000,000 individuals. Additional analyses were performed to categorize the underlying causes of death by organ systems. The study period was further stratified into three groups when specific drug regimens were more prevalent: 1999-2007 (MTR), 2008-2014 (STR) and 2015-2020 (INI). RESULTS: In the 22-year study period, 251,759 all-cause mortalities with comorbid HIV in the United States were identified. The most common cause of death was infectious diseases (84.0%, N=211,438), followed by neoplasms (5.3%, N=13,264) and diseases of the cardiovascular system (3.9%, N=9,797). The AAMR in HIV was also highest in infectious diseases at 3.12 per 1,000,000 individuals, followed by neoplasms (0.18 per 1,000,000 individuals), diseases of cardiovascular system (0.12 per 1,000,000 individuals), diseases of respiratory system (0.05 per 1,000,000 individuals) and diseases of gastrointestinal system (0.04 per 1,000,000 individuals). Further analysis of infectious related causes showed significantly decreased mortality trends from 134,726 (MTR) to 69,450 (STR) and 47,583 (INI). [Figure: see text] CONCLUSION: More than 80% of deaths in HIV occurred because of infectious disease over the past two decades. A decreasing trend was also seen in infectious related mortality in three different time periods. This reflects the improved tolerability and efficacy of ART over time. DISCLOSURES: Jihad Slim, MD, FACP, ViiV Healthcare: Advisor/Consultant|ViiV Healthcare: Grant/Research Support
format Online
Article
Text
id pubmed-10679375
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106793752023-11-27 1523. Impact of Antiretroviral Therapy (ART) on All-Cause Mortality in HIV from 1999 to 2020 in the United States Prince, Monique A Tan, Min-Choon Tan, Min-Xuan Prince, E’ebony Nicholas, Rick Shaaban, Hamid Slim, Jihad Open Forum Infect Dis Abstract BACKGROUND: Over the last two decades, Antiretroviral Therapy (ART) has evolved dramatically in the United States (U.S.) from multi-tablet regimens (MTR) to single tablet regimens (STR) and from Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) and Protease Inhibitor (PI) based regimens to integrase inhibitor (INI) based ART. This study sought to determine the trends in all-cause mortality over time as ART trends changed. METHODS: We queried the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database and performed serial cross-sectional analyses of national death certificate data for all-cause mortality with comorbid HIV from 1999 to 2020. HIV diseases (ICD-10 B20-B24, O98.7, R75) were listed as the contributing cause of death. We calculated age-adjusted mortality rates (AAMR) per 1,000,000 individuals. Additional analyses were performed to categorize the underlying causes of death by organ systems. The study period was further stratified into three groups when specific drug regimens were more prevalent: 1999-2007 (MTR), 2008-2014 (STR) and 2015-2020 (INI). RESULTS: In the 22-year study period, 251,759 all-cause mortalities with comorbid HIV in the United States were identified. The most common cause of death was infectious diseases (84.0%, N=211,438), followed by neoplasms (5.3%, N=13,264) and diseases of the cardiovascular system (3.9%, N=9,797). The AAMR in HIV was also highest in infectious diseases at 3.12 per 1,000,000 individuals, followed by neoplasms (0.18 per 1,000,000 individuals), diseases of cardiovascular system (0.12 per 1,000,000 individuals), diseases of respiratory system (0.05 per 1,000,000 individuals) and diseases of gastrointestinal system (0.04 per 1,000,000 individuals). Further analysis of infectious related causes showed significantly decreased mortality trends from 134,726 (MTR) to 69,450 (STR) and 47,583 (INI). [Figure: see text] CONCLUSION: More than 80% of deaths in HIV occurred because of infectious disease over the past two decades. A decreasing trend was also seen in infectious related mortality in three different time periods. This reflects the improved tolerability and efficacy of ART over time. DISCLOSURES: Jihad Slim, MD, FACP, ViiV Healthcare: Advisor/Consultant|ViiV Healthcare: Grant/Research Support Oxford University Press 2023-11-27 /pmc/articles/PMC10679375/ http://dx.doi.org/10.1093/ofid/ofad500.1358 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Prince, Monique A
Tan, Min-Choon
Tan, Min-Xuan
Prince, E’ebony
Nicholas, Rick
Shaaban, Hamid
Slim, Jihad
1523. Impact of Antiretroviral Therapy (ART) on All-Cause Mortality in HIV from 1999 to 2020 in the United States
title 1523. Impact of Antiretroviral Therapy (ART) on All-Cause Mortality in HIV from 1999 to 2020 in the United States
title_full 1523. Impact of Antiretroviral Therapy (ART) on All-Cause Mortality in HIV from 1999 to 2020 in the United States
title_fullStr 1523. Impact of Antiretroviral Therapy (ART) on All-Cause Mortality in HIV from 1999 to 2020 in the United States
title_full_unstemmed 1523. Impact of Antiretroviral Therapy (ART) on All-Cause Mortality in HIV from 1999 to 2020 in the United States
title_short 1523. Impact of Antiretroviral Therapy (ART) on All-Cause Mortality in HIV from 1999 to 2020 in the United States
title_sort 1523. impact of antiretroviral therapy (art) on all-cause mortality in hiv from 1999 to 2020 in the united states
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679375/
http://dx.doi.org/10.1093/ofid/ofad500.1358
work_keys_str_mv AT princemoniquea 1523impactofantiretroviraltherapyartonallcausemortalityinhivfrom1999to2020intheunitedstates
AT tanminchoon 1523impactofantiretroviraltherapyartonallcausemortalityinhivfrom1999to2020intheunitedstates
AT tanminxuan 1523impactofantiretroviraltherapyartonallcausemortalityinhivfrom1999to2020intheunitedstates
AT princeeebony 1523impactofantiretroviraltherapyartonallcausemortalityinhivfrom1999to2020intheunitedstates
AT nicholasrick 1523impactofantiretroviraltherapyartonallcausemortalityinhivfrom1999to2020intheunitedstates
AT shaabanhamid 1523impactofantiretroviraltherapyartonallcausemortalityinhivfrom1999to2020intheunitedstates
AT slimjihad 1523impactofantiretroviraltherapyartonallcausemortalityinhivfrom1999to2020intheunitedstates